Abstract
Semih Bilgili, Ahmet Kasım Kılıç, Ozlem Cakir Madenci
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria
10.1093/brain/awac220 · 2022
Kappa-free light chain as a practical alternative to oligoclonal bands in the diagnosis of multiple sclerosis
10.1016/j.msard.2025.106377 · 2025
Optimized Kappa-Index test protocol to detect intrathecal immunoglobulin synthesis in multiple sclerosis
10.1111/ene.70411 · 2025
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach
10.2307/2531595 · 1988
Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis
10.1111/ene.14121 · 2020
Multiple sclerosis
10.1038/s41572-018-0041-4 · 2018
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement
10.1001/archneur.62.6.865 · 2005
Brain health: time matters in multiple sclerosis
2016
Sex and gender issues in multiple sclerosis
10.1177/1756285613488434 · 2013
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a systematic review and meta-analysis
10.1177/13524585221134213 · 2023
Optimizing kappa free light chain index thresholds for multiple sclerosis (MS) diagnosis in low-MS prevalence regions: insights from an Asian cohort
10.1177/13524585251399102 · 2026
Oligoclonal bands and kappa free light chains: competing parameters or complementary biomarkers?
10.1016/j.autrev.2025.103765 · 2025
Kappa free light chains is a valid tool in the diagnostics of MS: a large multicenter study
10.1177/1352458519845844 · 2020
Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis
2015
Performance evaluation of serum free light chain analysis: nephelometry vs turbidimetry, monoclonal vs polyclonal reagents
10.1093/ajcp/aqx037 · 2017
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
10.1016/s1474-4422(25)00270-4 · 2025
Kappa free light chain index as a diagnostic and prognostic biomarker in multiple sclerosis
10.1007/s00415-025-13381-w · 2025
Cerebrospinal fluid biomarkers in differential diagnosis of multiple sclerosis and systemic inflammatory diseases with Central nervous system involvement
10.3390/biomedicines11020425 · 2023
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
10.1016/s1474-4422(17)30470-2 · 2018
Index for rating diagnostic tests
10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3 · 1950
No additional external references are available.